The evolution of alternatives to animal testing: A 3R timeline
For over a century, animal experimentation has served as the bedrock of biomedical research and toxicology.
Breast Cancer
A new era in preclinical testing: The 3D model for breast cancer immunotherapies
In oncological research, the development of a 3D model for breast cancer immunotherapies marks a pivotal
New approaches methodologies for hormone receptor-positive (Luminal A/B) breast cancer
Luminal A and B breast cancers, collectively known as hormone receptor–positive (HR+) disease, represent the most
SVF vs ADSC for 3D adipose culture: What source to use?
In this discussion, we investigate the optimal cell source for constructing 3D adipose models, predicated on
Applications of HER2+ organoids and NAMs to study breast cancer
HER2-positive breast cancer represents about one quarter of breast malignancies and is driven by amplification of
Triple-Negative Breast Cancer and the Application of Breast Cancer Organoid Models
Triple-negative breast cancer (TNBC) is a distinct pathological subtype defined by the absence of estrogen receptor
Scientific Poster – Development of a 3D immunocompetent breast cancer model to accelerate drug testing and personalised medicine
Authors: Priyanka Fernandes, Harry Dawson, Ethan N.P Vong, Pierre Savagner, Dario Fassini Breast cancer remains
Organoids for Lipid Metabolism: Organoid and Organ-on-Chip Models in Metabolic Disease Research
Understanding how the body processes fats is central to tackling obesity, type 2 diabetes, and fatty
10 key studies on breast cancer research powered by New Approach Methodologies (2024–2025)
Breast cancer remains the most common malignancy in women worldwide, and progress in treatment increasingly depends
What’s new in breast cancer research? – July-August 2025
Breast cancer is the second cancer-related cause of death in women worldwide, therefore it is no
get in touch
Get the best insights about Cherry Biotech by Email
Let’s stay in touch!